Please confirm topic selection

Are you sure you want to trigger topic in your Anconeus AI algorithm?

Please confirm action

You are done for today with this topic.

Would you like to start learning session with this topic items scheduled for future?

Updated: Jun 8 2026

Operative Blood Loss & Transfusion

  • Preoperative Management
    • Aimed at optimizing patient hemoglobin levels to allow for better patient stress tolerance at the time of surgery
      • erythropoietin (EPO)
        • studies have demonstrated greater efficacy than preoperative autologus blood donation and reinfusion systems
        • recommended for high risk patients (e.g. low preoperative hemoglobin, surgeries with significant blood loss anticipated, etc.)
      • preoperative autologous blood donation
        • preoperative procurement of 1 to 2 units of autologous blood
        • performed at least 3 weeks from the planned surgery to allow for recovery of hemoglobin levels
        • may be of benefit in patients with normal Hb (>14 g/dL) ubdergoing procedures with high expected blood loss
        • current literature does not seem to support efficacy and cost effectiveness in the management of postoperative anemia
      • preoperative embolization
        • performed within 24 hours of the procedure
  • Intraoperative Management
    • Acute normovolemic hemodilution
      • autologus blood harvested right before or at the time of surgery
        • removed volume is replaced with colloid
      • extracted blood is transfused in the perioperative period
      • requires less planning than preoperative autologus blood transfusion
      • not commonly performed due to increased time in OR and associated labor
    • Tourniquet
      • allows for a dry surgical field and better theoretical cement interdigitation during arthroplasty cases
      • minimum inflation pressure of 100 -150 mm Hg of systolic pressure
        • may also elevate limb for gravity exsanguination prior to inflating tourniquet
      • avoid use longer than 2 hours
      • tourniquets should be cautiously used in patients with severe peripheral vascular disease
        • preoperative vascular surgery consultation in high risk patients
    • Tranexamic acid (TXA)
      • lysine derivative that competitively blocks plasmin binding sites on fibrin
        • results in a decrease in fibrinolysis and stabilized clot formation
      • multiple studies have demonstrated a significant reduction in operative blood loss and transfusion rates with perioperative administration
        • no increased risk of DVT and PE
        • does not alter PT and PTT times
      • multiple dosing regimens and routes of administration utilized
        • IV, oral, and topical all appear equally efficacious
      • contraindications
        • active intravascular clotting
        • severe drug allergy (anaphylaxis)
        • subarachnoid hemorrhage
    • Aminocaproic acid
      • lysine derivative that competitively inhibits plasmin
        • results in decreased fibrinolysis
      • studies have demonstrated decreased blood loss with aminocaproic acid in arthroplasty
      • lower cost than TXA
      • does not decrease seizure threshold
    • Topical hemostatic agents
      • collagen agents
        • stimulate the instrinsic pathway of coagulation cascade to promote hemostasis
      • fibrin sealant
        • combining the mixtures creates a fibrin seal where it is sprayed
      • platelet-rich plasma
        • centrifugation of patient's blood to isolate plasma with high contents of platelets, growth factors, and clotting factors
        • proposed benefit of improved hemostasis, wound healing and recovery
      • platelet-poor plasma
        • isolated from centrifugation process
        • combined with thrombin and calcium to provide an autologous fibrin sealant
      • gelfoam sponges
        • manufactured from animal-skin gelatin and processed into sponge-form
        • isolated use exerts mostly mechanical hemostasis against low-pressure bleeders
        • can be soaked with thrombin, which can act as a scaffold for the coagulation cascade
        • excess gelfoam should be removed as it may interfere with bone healing
      • topical hemostatic agents do not appear to be cost-effective in total joint arthroplasty cases
        • beneficial in spine surgery to promote hemostasis without inflicting harm to adjacent neural structures
      • topical TXA
        • typically administered near the end of the procedure to control postoperative bleeding
        • decreases fibrinolysis and stabilizes clot formation
      • gelatin-thrombin matrix
        • consists of porcine or bovine gelatine matrix combined with human derived thrombin
        • acts at the end stage of the coagulation cascade leading to fibrin formation
    • Reinfusion systems (cell saver)
      • recycles intraoperative blood loss for later transfusion
        • can be transfused intraoperatively during longer procedure
      • collected blood is filtered, washed, and transfused within 6 to 8 hours from the procedure
        • serves as an alternative to allogenic blood transfusion
        • theoretical benefits of minimizing wound complications and hematoma formation
  • Postoperative Management
    • Allogenic blood transfusion
      • preoperative hemoglobin strongest risk factor for postoperative blood transfusion
      • other risk factors
        • female gender
        • increased age
        • larger patient size
        • longer procedures
        • lateral releases in total knee arthroplasty
      • 1 unit of packed red blood cells generally increases hemoglobin by 1 g/dL
      • no absolute criteria for transfusion
        • transfusion should especially be considered at hemoglobin <8 g/dL
    • Postoperative iron supplementation
      • daily oral iron supplementation for mild acute blood loss anemia related to surgery
  • Special Consideration
    • Jehovah's Witness (JW)
      • hold beliefs that blood transfusions are forbidden by the Bible
        • some patients may still consent to a blood transfusion
        • some patients may consider the use of cell saver as an alternative to allogenic blood transfusion
      • use of colloids and coagulation factors are not forbidden and a matter of personal choice
      • bovine-derived hemostatic agents are generally approved by JW
flashcard locked
Create a free account or log in to see the cards.
Question
1 of 3
Basic Science⎪ Operative Blood Loss & Transfusion
  • Basic Science
  • - Operative Blood Loss & Transfusion
19:36 min
12/8/2020
337 plays
5.0
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
  • star icon star icon star icon
(2)
Private Note